Company profile
MoonLake Immunotherapeutics (NASDAQ: MLTX)
Creating next-level therapies for inflammatory skin and joint diseases with Nanobody® science
- Industry
- Biotechnology Research
- Employees
- 139
- Headquarters
- Zug, Zug
- Founded
- 2021
- LinkedIn followers
- 9,817
- Office locations
- 1
MoonLake Immunotherapeutics (NASDAQ: MLTX) company summary
MoonLake Immunotherapeutics (NASDAQ: MLTX) is a company in the Biotechnology Research industry, headquartered in Zug, Zug, founded in 2021. On LinkedIn the company has around 139 employees and 9,817 followers. Its listed specialties include Immunotherapy, inflammatory skin & joint diseases, partnering, IL17A / F, #MLTX.
What technology does MoonLake Immunotherapeutics (NASDAQ: MLTX) use?
No technologies detected yet. Warmrank rechecks company websites on a rolling basis.
About MoonLake Immunotherapeutics (NASDAQ: MLTX)
MoonLake Immunotherapeutics AG is a clinical-stage biopharmaceutical company leveraging revolutionary Nanobody® technology to develop next-level medicines for immunologic diseases, including inflammatory skin and joint diseases.
Specialties
Where is MoonLake Immunotherapeutics (NASDAQ: MLTX) located?
MoonLake Immunotherapeutics (NASDAQ: MLTX) lists 1 location.
Compare companies similar to MoonLake Immunotherapeutics (NASDAQ: MLTX)
More companies in Biotechnology Research.
| Company | Industry | Employees | Founded | Headquarters |
|---|---|---|---|---|
MoonLake Immunotherapeutics (NASDAQ: MLTX) moonlaketx.com | Biotechnology Research | 139 | 2021 | Zug, Zug |
 Thermo Fisher Scientific thermofisher.com | Biotechnology Research | 100,779 | - | Waltham, MA |
 Amgen amgen.com | Biotechnology Research | 41,028 | 1980 | Thousand Oaks, CA |
 Biogen biogen.com | Biotechnology Research | 7,742 | - | Cambridge, MA |
 Biocon biocon.com | Biotechnology Research | 11,902 | - | Bangalore, Karnataka |
| Biotechnology Research | 28,679 | - | Bethesda, MD | |
 Genentech gene.com | Biotechnology Research | 18,296 | 1976 | South San Francisco, California |
 Eurofins eurofins.com | Biotechnology Research | 24,928 | - | Luxembourg, Luxembourg |
 Gilead Sciences gilead.com | Biotechnology Research | 14,743 | - | Foster City, CA |
 Syneos Health syneoshealth.com | Biotechnology Research | 23,772 | - | Morrisville, NC |
 Moderna modernatx.com | Biotechnology Research | 6,238 | 2010 | Cambridge, Massachusetts |
Frequently asked questions about MoonLake Immunotherapeutics (NASDAQ: MLTX)
What does MoonLake Immunotherapeutics (NASDAQ: MLTX) do?
MoonLake Immunotherapeutics AG is a clinical-stage biopharmaceutical company leveraging revolutionary Nanobody® technology to develop next-level medicines for immunologic diseases, including inflammatory skin and joint diseases.
How many employees does MoonLake Immunotherapeutics (NASDAQ: MLTX) have?
MoonLake Immunotherapeutics (NASDAQ: MLTX) has around 139 employees on LinkedIn.
Where is MoonLake Immunotherapeutics (NASDAQ: MLTX) headquartered?
MoonLake Immunotherapeutics (NASDAQ: MLTX) is headquartered in Zug, Zug.
When was MoonLake Immunotherapeutics (NASDAQ: MLTX) founded?
MoonLake Immunotherapeutics (NASDAQ: MLTX) was founded in 2021.
Build a lead list from companies like MoonLake Immunotherapeutics (NASDAQ: MLTX)
Describe your ICP or import a CSV. Warmrank finds matching companies, enriches contacts with verified emails, and tracks every lead.